Share your story and shine at JK Monitor!đ Welcome to JK Monitor, where every story matters and every achievement is celebrated! We invite you to share the remarkable journey of your life and showcase your accomplishments to the world. Join our exclusive interviews that honor exceptional individuals just like you. CHANDIGARH: Venus Foundation Trust, the not-for-profit Corporate Social Responsibility arm of Venus Remedies Ltd., has signed a Memorandum of Understanding (MoU) with the Government of Himachal Pradesh to support child welfare, education, and holistic development across Child Care Institutions (CCIs) in the state.
The MoU was formally signed by the Deputy Commissioner, Hamirpur, in the presence of the District Child Protection Officer (DCPO), underscoring the district administrationâs strong commitment to strengthening institutional care through meaningful publicâprivate partnerships.
Under the collaboration, Venus Foundation Trust will design, sponsor, and implement thoughtfully curated programmes to enhance educational access, experiential learning, recreational exposure, and welfare infrastructure for children residing in CCIs and other government-supported facilities. All initiatives will be fully funded by the Foundation and carried out in close coordination with district authorities, with a strong emphasis on child safety, dignity, and strict adherence to statutory and child protection guidelines.
The District Administration will facilitate approvals, coordination, and institutional support to ensure smooth implementation.
Aligned with the stateâs vision, the partnership seeks to ensure that children in institutional care receive not only protection and essential services, but also opportunities that build confidence, broaden horizons, and support their overall development.
Commenting on the collaboration, Ekta S. Chaudhary, Chairperson, Venus Foundation, said, âAt Venus Foundation, our work is guided by a simple belief â that meaningful social impact is created when care, education, and exposure come together to shape confidence and opportunity. Rooted in the values of Venus Remedies, our approach focuses on building long-term, enabling ecosystems rather than short-term or one-off interventions. We believe every child deserves opportunities that inspire confidence, learning, and hope for the future.â
The partnership will be operationalized through on-ground initiatives, beginning with an educational and recreational exposure visit for children from Bal Ashram, Sujanpur. Sponsored entirely by Venus Foundation Trust, the children will travel via Chandigarh to Jaipur, where they will spend several days exploring historical monuments, cultural and religious sites, and educational institutions. With comfortable travel arrangements and supervised stays, the visit is designed to provide enriching experiences and learning opportunities beyond the classroom. Through this collaboration, Venus Foundation Trust aims to strengthen child care institutions and create supportive environments that empower every child to thrive.
About Venus Remedies Ltd (venusremedies.com)
Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 90+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. The company holds the GMP approvals from European- GMP (INFARMED), PIC/S (Malaysia & Ukraine), SAHPRA, UNICEF, TGA, INVIMA & WHO-GMP, alongside key ISO certifications for quality, environmental, and occupational health and safety management.
Central to its mission, Venus Remedies is a frontrunner in combating antimicrobial resistance (AMR) through its dedicated research division, Venus Medicine Research Centre (VMRC). The company is pivotal in developing advanced antibiotics and ÎČ-lactam/ÎČ-lactamase inhibitor combinations aimed at tackling multidrug-resistant pathogens. Its notable initiatives like GASAR provide essential data on antibiotic resistance, while the PLEA Trust fosters antibiotic stewardship.
As an influential member of the AMR Industry Alliance, India AMR Innovation Hub, and Vivli AMR Registry, Venus Remedies shapes global AMR research and policy. Through strategic collaborations with academic and health organizations worldwide, the company enhances AMR surveillance and supports innovative drug development, affirming its leadership in global healthcare.